|
|
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.United States |
First Approval Date04 Sep 1964 |
|
Mechanismβ2-adrenergic receptor antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Varsity Pharmaceuticals Ltd.
0 Patents (Medical) associated with Varsity Pharmaceuticals Ltd.
100 Deals associated with Varsity Pharmaceuticals Ltd.
100 Translational Medicine associated with Varsity Pharmaceuticals Ltd.